Investing Profile

Frank Kalkbrenner

InvestorVC

Director, Investment Manager at Boehringer Ingelheim Venture Fund

Photo of Frank Kalkbrenner, Investor at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Boehringer Ingelheim Venture Fund Investor
$100K - $5.0M
$1.5M
4
CompanyStageDateRound SizeTotal Raised
Rinri Therapeutics
Venture RoundApr 2021€10M
€10M
£1.4M
Co-investors: Claire Brown (Oxford Science Enterprises)
T3 Pharmaceuticals
Series CJul 2020CHF25M
C25M
Amal Therapeutics
Series BNov 2018€29M
€29M
Hookipa Pharma
Series BNov 2013€20M
€20M
Co-investors: Graziano Seghezzi (Soffinova Partners)